Aligos Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-04-12
- Employees
- 66
- Market Cap
- -
- Website
- http://www.aligos.com
- Introduction
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to ...
A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects
- First Posted Date
- 2020-07-24
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Aligos Therapeutics
- Target Recruit Count
- 103
- Registration Number
- NCT04485663
- Locations
- 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
🇨🇳The First Hospital of Jilin University, Changchun, Jilin, China
🇰🇷Pusan National University Hospital, Busan, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath